As Vice President and Head of Translational Science & 实验医学 for 心血管,肾脏和代谢 (CVRM), 我负责澳门第一赌城在线娱乐的人类目标验证, biomarker and precision medicine departments, working closely with team leaders in both early and late CVRM研究. I help to direct our early-stage research priorities in CVRM and am involved in a multitude of initiatives across our early CVRM portfolio.
Our team’s collective ambition is to stop, 反向, 有一天, cure CRVM diseases by delivering innovative, life-changing medicines and solutions to patients. Across our departments, patients are always the starting point of our work. 为此目的, the foundation of our research relies heavily on human clinical data and biological samples, rather than cellular or animal modelling.
I completed my PhD and MD at the University of 剑桥, Departments of Clinical Biochemistry and Medicine and am currently a practicing endocrinologist. The time I spend with patients shapes my understanding of their needs as well as the gaps they experience in existing healthcare systems. This is both rewarding and incredibly valuable to the work I do each day at 澳门在线赌城娱乐.
Working across industry and applied medicine, a key priority for me as department head is ensuring we have a clear purpose as a team. I encourage open communication of priorities to foster a collaborative and stimulating work environment where we can work together to push the boundaries of science to deliver life-changing medicines to our patients.
As a full-time consultant, I was not able to conduct the research that I was passionate about. What attracted me to 澳门在线赌城娱乐 was the breadth and depth of their research programmes, 特别是在crvrm疾病中. My role now allows me to be at the forefront of cutting-edge clinical research, while still seeing patients as a practicing clinician; it’s both exciting and fulfilling.
电流的作用
2021年至今
2019 – 2021
2016 – 2019
2016年至今
科学出版物
Effects of protein-coding variants on blood metabolite measurements and clinical biomarkers in the UK Biobank
唠叨了., Dhindsa R.S.米德尔顿·L. 等. 我是热内吗. 2023 Feb 10:S0002-9297(23)00046-0. doi: 10.1016/j.ajhg.2023.02.002.
Human genetics uncovers MAP3K15 as an obesity-independent therapeutic target for diabetes
唠叨了., Dhindsa R.S.米切尔·J. 等. Sci副词. 2022年11月18日;8(46):eadd5430. doi: 10.1126 / sciadv.add5430.
Rare variant contribution to human disease in 281,104 UK Biobank exomes
王问., Dhindsa R.S.,卡斯·K. 等. 自然. 2021年9月,597 (7877):527 - 532. doi: 10.1038/s41586-021-03855-y.
HEROIC: a 5-year observational cohort study aimed at identifying novel factors that drive diabetic kidney disease: rationale and study protocol
McCafferty K, Caplin B, Knight S 等. BMJ开放. 2020;10:e033923. doi: 10.1136 / bmjopen - 2019 - 033923
Veeva ID: Z4-54154
编制日期:2023年4月